Bio Protocol vs Moonbeam — how do they compare? Bio Protocol trades at Rp514.44 (market cap Rp1,16T, Rp252,63M 24h volume), while Moonbeam trades at Rp157.37 (market cap Rp186,94M, Rp81,1M 24h volume). The key difference: Bio Protocol is far larger — about 6205.2× Moonbeam's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Moonbeam's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Moonbeam for 48 Days on average.
| BIO | GLMR | |
|---|---|---|
Market Cap | Rp1,16T | Rp186,94M |
Volume (24h) | Rp252,63M | Rp81,1M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 1,2B GLMR |
Typical Hold Time | 16 Days | 48 Days |
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Moonbeam is an Ethereum-compatible smart contract parachain on Polkadot. Through Moonbeam, developers can port their existing Ethereum dApps to Polkadot or easily create new permissionless dApps using familiar Ethereum development tools. Ethereum developers will also be able to bypass the scalability challenges due to the expense and constraints of the Ethereum network.
Read more on GLMR →